Biomarker identification for a better care of diabetic cardiomyopathy
LIH is a partner in CARDIATEAM, a large translational research project funded by the Innovative Medicines Initiative IMI2, aiming to find novel biomarkers to diagnose and treat diabetic cardiomyopathy.
LIH gut microbiome research as the cover story of a leading news magazine Der Spiegel
A widely read and generally considered as one the most influential news magazines of continental Europe, Der Spiegel, published its latest cover story focussed on human gut microbiome research.
The Cancer Foundation supports a research project on a novel therapeutic protein for Glioblastoma
The Cancer Foundation (Fondation Cancer) funds a research project on brain cancer at the NorLux Neuro-Oncology Laboratory in LIH’s Department of Oncology.
LIH allergology researchers distinguished at Europe's largest allergy conference
LIH was well represented at this year’s annual Congress of the European Academy of Allergy and Clinical Immunology (EAACI) to communicate on the successful projects in allergy research conducted in Luxembourg.
NextImmune PhD retreat 2019: insights into hot immunology topics
The second scientific retreat of the Doctoral Training Unit (DTU) NextImmune took place at the Alvisse Parc Hotel in Luxembourg from 7th to 9th May 2019.
Philanthropy supporting cancer research
The Laboratory of Oncolytic Virus Immuno-Therapeutics (LOVIT) at LIH’s Department of Oncology received a generous private donation to support its activities in cancer research.
Affiliated Professorships with University of Luxembourg
Prof Ulf Nehrbass, CEO of LIH, and Prof Laetitia Huiart, Director of the Department of Population Health, have been appointed as affiliated professors at the University of Luxembourg.
Restoring the anti-tumour immune response - a new research project funded by the Cancer Foundation
Luxembourg’s Cancer Foundation (Fondation Cancer) supports a new research project from LIH that aims to evaluate the effectiveness of targeting a new mechanism named the “actin response.